SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

被引：6
|
作者：
Ghosh, Arun K. [1 ,2 ]
Shahabi, Dana [1 ,2 ]
Imhoff, Mackenzie E. C. [3 ]
Kovela, Satish [1 ,2 ]
Sharma, Ashish [1 ,2 ]
Hattori, Shin-ichiro [4 ]
Higashi-Kuwata, Nobuyo [4 ]
Mitsuya, Hiroaki [4 ,5 ,6 ]
Mesecar, Andrew D. [7 ]
机构：
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[4] Natl Ctr Global Hlth & Med, Dept Refractory Viral Dis, Shinjuku Ku, Tokyo 1628655, Japan
[5] Kumamoto Univ Hosp, Dept Clin Sci, Kumamoto 8608556, Japan
[6] Natl Canc Inst, HIV & AIDS Malignancy Branch, Expt Retrovirol Sect, Bethesda, MD 20817 USA
[7] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2023年 / 96卷
关键词：
Antiviral; Covid-19; Inhibitor; SARS-CoV-2; protease; Synthesis;
D O I：
10.1016/j.bmcl.2023.129489
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report here the synthesis and biological evaluation of a series of small molecule SARS-CoV-2 PLpro inhibitors. We compared the activity of selected compounds in both SARS-CoV-1 and SARS-CoV-2 PLpro inhibitory and antiviral assays. We have synthesized and evaluated several new structural variants of previous leads against SARS-CoV-2 PLpro. The replacement of the carboxamide functionality with sulfonamide derivatives resulted in PLpro inhibitors with potent PLpro inhibitory and antiviral activity in VeroE6 cells similar to GRL0617. To obtain molecular insight, we created an optimized model of a potent sulfonamide derivative in the SARS-CoV-2 PLpro active site.
引用
收藏
页数：6
相关论文
共 50 条
  • [31] A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals
    Jimenez-Campos, Anahi G.
    Maestas, Lucas I.
    Velappan, Nileena
    Beck, Brian
    Ye, Chunyan
    Wernsing, Keith
    Mata-Solis, Yaniksa
    Bruno, William J.
    Bussmann, Silas C.
    Bradfute, Steven
    Baca, Justin T.
    Rininsland, Frauke H.
    PLOS ONE, 2024, 19 (12):
  • [32] Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro
    Kiba, Yuka
    Tanikawa, Takashi
    Kitamura, Masashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (05) : 965 - 966
  • [33] Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
    Ma, Chunlong
    Wang, Jun
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (02) : 102 - 109
  • [34] SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition
    Ullrich, Sven
    Nitsche, Christoph
    CHEMBIOCHEM, 2022, 23 (19)
  • [35] Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
    Tan, Haozhou
    Hu, Yanmei
    Jadhav, Prakash
    Tan, Bin
    Wang, Jun
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (11) : 7561 - 7580
  • [36] Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
    Tan, Jinlin
    Wu, Zhilong
    Hu, Peipei
    Gan, Lin
    Wang, Ying
    Zhang, Dingmei
    PATHOGENS, 2022, 11 (09):
  • [37] Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
    Ibrahim, Tamer M.
    Ismail, Muhammad I.
    Bauer, Matthias R.
    Bekhit, Adnan A.
    Boeckler, Frank M.
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [38] Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency
    Rouch, Catherine C.
    Chatterjee, Arnab K.
    Mccarty, Connor
    Song, Lirui
    Chu, Alan
    Johnson, Kristen
    Heacock, Mina
    Riva, Laura
    Mcnamara, Case W.
    Wolff, Karen C.
    Greene-Cramer, Rebecca
    De Falco, Anna
    Montelione, Gaetano T.
    Grabovyi, Gennadii A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 116
  • [39] Drug Repurposing for the SARS-CoV-2 Papain-Like Protease (vol 17, 202100455, 2022)
    Cho, Chia-Chuan
    Li, Shuhua G.
    Lalonde, Tyler J.
    Yang, Kai S.
    Yu, Ge
    Qiao, Yuchen
    Xu, Shiqing
    Ray Liu, Wenshe
    CHEMMEDCHEM, 2022, 17 (05)
  • [40] Deubiquitinating activity of the SARS-CoV papain-like protease
    Barretto, Naina
    Jukneliene, Dalia
    Ratia, Kiira
    Chen, Zhongbin
    Mesecar, Andrew D.
    Baker, Susan C.
    NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 37 - 41
12345